A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene.
about
Patient healthcare trajectory. An essential monitoring tool: a systematic review.Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesotheliomaThe Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.Tumor angiogenesis and anti-angiogenic gene therapy for cancer.
P2860
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A clinical protocol to inhibit ...... ruses expressing the NK4 gene.
@ast
A clinical protocol to inhibit ...... ruses expressing the NK4 gene.
@en
type
label
A clinical protocol to inhibit ...... ruses expressing the NK4 gene.
@ast
A clinical protocol to inhibit ...... ruses expressing the NK4 gene.
@en
prefLabel
A clinical protocol to inhibit ...... ruses expressing the NK4 gene.
@ast
A clinical protocol to inhibit ...... ruses expressing the NK4 gene.
@en
P2093
P2860
P1433
P1476
A clinical protocol to inhibit ...... iruses expressing the NK4 gene
@en
P2093
Hideaki Shimada
Ikuo Sekine
Kenzo Hiroshima
Koichiro Tatsumi
Masato Shingyoji
Masatoshi Tagawa
Naoya Morishita
P2860
P2888
P356
10.1186/S40064-015-1123-3
P577
2015-07-16T00:00:00Z
P5875
P6179
1046706044